---
title: Bronchodilators
---
# Bronchodilators

* (1st-line): long-acting muscarinic antag (LAMA), β2-agonists (LABA)

## LAMA (eg, tiotropium): 
↓ exacerb, 
slows ↓ FEV1, 
↓ admit, 
↓ resp failure; 
better than [[ipratropium]] or LABA (NEJM 2008;359:1543; 2011;364:1093; 2017;377:923)

## LABA: 
~11% ↓ in exacerbations, 
no ↑ in CV events (Lancet 2016;387:1817)

## LAMA + LABA: 
↑ FEV1, ↓ sx vs. either alone (Chest 2014;145:981) and superior to LABA + inh steroid (NEJM 2016;374:2222)
